Author

M. Smits

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

A. J. Kuipers· 1 shared A. Lavrova· 1 shared A. Li· 1 shared A. M. Bergman· 1 shared A. Thom· 1 shared B. Berkeveld· 1 shared B. Boers· 1 shared B. Kazemier· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. J. Kuipers

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling

W. R. Vallentgoed, Y. Hoogstrate, K. A. van Garderen, L. van Hijfte, E. van Dijk, M. C. Kouwenhoven, J. M. Niers, K. Draaisma, I. Martin, W. W. de Leng, C. M. S. Tesileanu, I. de Heer, M. Diepeveen, A. Lavrova, P. P. Eijk, , P. J. French

The paper analyzes multi-omics data from IDH-mutant astrocytomas to identify molecular markers of malignant progression linked to cell cycling and DNA methylation changes.

bioRxiv · Mar 5, 2024Cancer Biology

Cornering an Ever-Evolving Coronavirus: TATX-03, a fully human synergistic multi-antibody cocktail targeting the SARS-CoV-2 Spike Protein with in vivo efficacy

I. Roodink, M. van Erp, A. Li, S. Potter, S. M. J. van Duijnhoven, A. J. Kuipers, B. Kazemier, E. van Geffen, W. Hemrika, B. Berkeveld, G. Sonnemans, B. S. de Vries, B. Boers, M. Smits, S. Meurs, , Y. N. Abdiche

This paper describes the development of a multi-antibody cocktail (TATX-03) that effectively neutralizes SARS-CoV-2 in vivo and maintains potency against variants of concern.

bioRxiv · Jul 20, 2021 · PreprintImmunology

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

L. F. van Dessel, J. van Riet, M. Smits, Y. Zhu, P. Hamberg, M. S. van der Heijden, A. M. Bergman, I. M. van Oort, R. de Wit, E. E. Voest, N. Steeghs, T. N. Yamaguchi, J. Livingstone, P. C. Boutros, J. W. M. Martens, , M. P. Lolkema

This study uses whole-genome sequencing to identify four distinct genotypes in metastatic castration-resistant prostate cancers, with potential clinical implications for patient stratification.

bioRxiv · Oct 7, 2019Cancer Biology